BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12085566)

  • 21. Chemokines and autoimmune thyroid diseases.
    Liu C; Papewalis C; Domberg J; Scherbaum WA; Schott M
    Horm Metab Res; 2008 Jun; 40(6):361-8. PubMed ID: 18418812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.
    Ryckman C; McColl SR; Vandal K; de Médicis R; Lussier A; Poubelle PE; Tessier PA
    Arthritis Rheum; 2003 Aug; 48(8):2310-20. PubMed ID: 12905486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix.
    Savino W; Mendes-Da-Cruz DA; Smaniotto S; Silva-Monteiro E; Villa-Verde DM
    J Leukoc Biol; 2004 Jun; 75(6):951-61. PubMed ID: 15020651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines and anti-cytokines as therapeutics--an update.
    Tayal V; Kalra BS
    Eur J Pharmacol; 2008 Jan; 579(1-3):1-12. PubMed ID: 18021769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blockade of chemokines in chronic inflammatory diseases].
    Haringman JJ; Tak PP
    Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1760-4. PubMed ID: 15495938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M; Jonakait GM; Ganea D
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine patterns and pathogenicity in autoimmune diseases.
    Matei I; Matei L
    Rom J Intern Med; 2002; 40(1-4):27-41. PubMed ID: 15526538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis.
    Shin JJ; Glickstein LJ; Steere AC
    Arthritis Rheum; 2007 Apr; 56(4):1325-35. PubMed ID: 17393419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
    Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
    Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.
    Gijsbers K; Van Assche G; Joossens S; Struyf S; Proost P; Rutgeerts P; Geboes K; Van Damme J
    Eur J Immunol; 2004 Jul; 34(7):1992-2000. PubMed ID: 15214047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokines in joint disease: the key to inflammation?
    Haringman JJ; Ludikhuize J; Tak PP
    Ann Rheum Dis; 2004 Oct; 63(10):1186-94. PubMed ID: 15082471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
    Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
    Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression].
    Ntayi C; Hornebeck W; Bernard P
    Pathol Biol (Paris); 2004 Apr; 52(3):154-9. PubMed ID: 15063935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
    Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
    Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary role of growth-related oncogene-alpha and granulocyte chemotactic protein-2 as neutrophil chemoattractants in chronic rhinosinusitis.
    Rudack C; Sachse F; Alberty J
    Clin Exp Allergy; 2006 Jun; 36(6):748-59. PubMed ID: 16776676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Type IV collagenases (MMP-2 and MMP-9) and their substrates--intracellular proteins, hormones, cytokines, chemokines and their receptors].
    Hrabec E; Naduk J; Strek M; Hrabec Z
    Postepy Biochem; 2007; 53(1):37-45. PubMed ID: 17718386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes.
    Qiu Z; Dillen C; Hu J; Verbeke H; Struyf S; Van Damme J; Opdenakker G
    Immunobiology; 2009; 214(9-10):835-42. PubMed ID: 19628296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
    Jacques C; Gosset M; Berenbaum F; Gabay C
    Vitam Horm; 2006; 74():371-403. PubMed ID: 17027524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
    Matsumoto Y; Park IK; Kohyama K
    J Immunol; 2009 Oct; 183(7):4773-81. PubMed ID: 19734212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.